BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2895838)

  • 1. Mechanisms for the early mortality reduction produced by beta-blockade started early in acute myocardial infarction: ISIS-1. ISIS-1 (First International Study of Infarct Survival) Collaborative Group.
    Lancet; 1988 Apr; 1(8591):921-3. PubMed ID: 2895838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomised trial of intravenous atenolol among 16 027 cases of suspected acute myocardial infarction: ISIS-1. First International Study of Infarct Survival Collaborative Group.
    Lancet; 1986 Jul; 2(8498):57-66. PubMed ID: 2873379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of beta adrenoceptor blockade during and after acute myocardial infarction.
    Sleight P
    Annu Rev Med; 1986; 37():415-25. PubMed ID: 2871805
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beta blockade early in acute myocardial infarction.
    Sleight P
    Am J Cardiol; 1987 Jul; 60(2):6A-10A. PubMed ID: 2887100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predictors of late hospital death in acute myocardial infarction.
    Norris RM; Sammel NL
    Prog Cardiovasc Dis; 1980; 23(2):129-40. PubMed ID: 6997924
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early intravenous atenolol treatment in suspected acute myocardial infarction. Preliminary report of a randomised trial.
    Yusuf S; Ramsdale D; Peto R; Furse L; Bennett D; Bray C; Sleight P
    Lancet; 1980 Aug; 2(8189):273-6. PubMed ID: 6105436
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction.
    Yusuf S; Sleight P; Rossi P; Ramsdale D; Peto R; Furze L; Sterry H; Pearson M; Motwani R; Parish S; Gray R; Bennett D; Bray C
    Circulation; 1983 Jun; 67(6 Pt 2):I32-41. PubMed ID: 6851037
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Göteborg metoprolol trial. Effects on mortality and morbidity in acute myocardial infarction.
    Hjalmarson A; Herlitz J; Holmberg S; Rydén L; Swedberg K; Vedin A; Waagstein F; Waldenström A; Waldenström J; Wedel H; Wilhelmsen L; Wilhelmsson C
    Circulation; 1983 Jun; 67(6 Pt 2):I26-32. PubMed ID: 6342837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mortality in 709 patients with acute myocardial infarct treated in the intensive care unit].
    Eichhorn P; Vuilliomenet A; Levis P; Bertel O
    Schweiz Med Wochenschr; 1988 Oct; 118(39):1398-402. PubMed ID: 3175578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prophylaxis of ventricular fibrillation after acute experimental coronary occlusion by chronic beta-adrenoceptor blockade with atenolol.
    Menken U; Wiegand V; Bucher P; Meesmann W
    Cardiovasc Res; 1979 Oct; 13(10):588-94. PubMed ID: 519661
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary prevention of cardiac events following myocardial infarction: effects of atenolol and enalapril. Beijing Collaborative Study Group.
    Wu N; Fan Z
    Chin Med J (Engl); 1997 Aug; 110(8):602-6. PubMed ID: 9594263
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Do results from major clinical trials indicate a change in management in the acute phase of myocardial infarction?
    Hjalmarson A
    J Cardiovasc Pharmacol; 1987; 10 Suppl 2():S2-8; discussion S9. PubMed ID: 2481164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial.
    Chen ZM; Pan HC; Chen YP; Peto R; Collins R; Jiang LX; Xie JX; Liu LS;
    Lancet; 2005 Nov; 366(9497):1622-32. PubMed ID: 16271643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Therapy of cardiogenic shock in acute myocardial infarct].
    Görge G; Haude M; Baumgart D; Sack S; Ge J; Leischik R; Erbel R
    Herz; 1994 Dec; 19(6):360-70. PubMed ID: 7843692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapy with beta receptor blockers in myocardial infarct].
    Hohnloser SH; Klingenheben T
    Z Kardiol; 1994 Nov; 83(11):824-9. PubMed ID: 7825372
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of the causes of death due to acute coronary insufficiency and myocardial infarct (analysis of outpatient and inpatient mortality)].
    Shkhvatsabaia IK; Raĭskina ME; Opaleva-Stegantseva VA; Ostapova VN; Ratovskaia VI
    Kardiologiia; 1974 Jun; 14(6):18-27. PubMed ID: 4444129
    [No Abstract]   [Full Text] [Related]  

  • 17. Metoprolol in acute myocardial infarction (MIAMI). A randomised placebo-controlled international trial. The MIAMI Trial Research Group.
    Eur Heart J; 1985 Mar; 6(3):199-226. PubMed ID: 2863148
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous beta-blockade during acute myocardial infarction.
    Lancet; 1986 Jul; 2(8498):79-80. PubMed ID: 2873383
    [No Abstract]   [Full Text] [Related]  

  • 19. Trial of heparin versus atenolol in prevention of myocardial infarction in intermediate coronary syndrome.
    Telford AM; Wilson C
    Lancet; 1981 Jun; 1(8232):1225-8. PubMed ID: 6112564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of sodium nitroprusside on mortality in acute myocardial infarction.
    Durrer JD; Lie KI; van Capelle FJ; Durrer D
    N Engl J Med; 1982 May; 306(19):1121-8. PubMed ID: 7040955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.